stocksSENORES
SENORES

Senores Pharmaceuticals Ltd.

1,405.10-48.0 (-3.30%)
17 Jul, 12:00 AM

Annual Reports and Financial Documents

Senores Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
202420252026
Annual ReportsFY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Senores Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General7 Jul 2026
    Submission Of Reconciliation Of Share Capital Audit Report For The Quarter Ended June 30, 2026
    Senores Pharmaceuticals Limited has informed the Exchange regarding submission of Reconciliation of Share Capital Audit Report for quarter ended June 30, 2026 under Regulation 76 of SEBI ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Senores Pharmaceuticals Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended June 30, 2026
  • Newspaper Publication3 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication
  • Postal Ballot2 Jul 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Senores Pharmaceuticals Limited has informed the Exchange regarding Postal Ballot Notice
  • Analyst / Investor Meet1 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on July 07, 2026.
  • Outcome without intimation29 Jun 2026
    Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On June 29, 2026
    Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting of the Company held on June 29, 2026
  • Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Senores Pharmaceuticals Limited has informed the Exchange regarding closure of trading window
  • General10 Jun 2026
    Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
    Senores Pharmaceuticals Limited has informed the Exchange regarding update in terms of Regulation 30(5) of SEBI (LODR) Regulations, 2015
  • Resignation of Company Secretary / Compliance Officer10 Jun 2026
    Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
    Senores Pharmaceuticals Limited has informed the Exchange regarding Cessation of Company Secretary and Compliance Offer w.e.f. June 10, 2026
  • Analyst / Investor Meet9 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on June 12, 2026.
  • Analyst / Investor Meet4 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on June 09, 2026.
  • Analyst / Investor Meet22 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on May 28, 2026.
  • Reg.24(A)-Annual Secretarial Compliance21 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Senores Pharmaceuticals Limited has informed the Exchange regarding submission of Annual Secretarial Compliance Report for financial year ended March 31, 2026
  • Analyst / Investor Meet20 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on May 25, 2026.
  • Newspaper Publication15 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication for Audited Consolidated and Standalone financial results for quarter and financial year ....
  • Analyst / Investor Meet14 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and financial year ended March 31, 2026.
  • General14 May 2026
    Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue Of Convertible Equity Warrants, For The Quarter Ended On March 31, 2026
    Senores Pharmaceuticals Limited has informed the Exchange regarding statement of deviation or variation in respect of funds raised through preferential issue of warrants.
  • Press Release / Media Release (Revised)14 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
    Senores Pharmaceuticals Limited has informed the Exchange regarding a corrigendum to the Media Release submitted with the Outcome of the Board Meeting dated May 14, 2026
  • General14 May 2026
    Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On March 31, 2026
    Senores Pharmaceuticals Limited has informed the Exchange regarding statement of Deviation or Variation for quarter ended on March 31, 2026
  • Monitoring Agency Report14 May 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended March 31, 2026

Frequently Asked Questions

Where can I download the annual report of Senores Pharmaceuticals Ltd.?
Annual reports of Senores Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Senores Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Senores Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Senores Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Senores Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Senores Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Senores Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Senores Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Senores Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Senores Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Senores Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Senores Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Senores Pharmaceuticals Ltd. is INE0RB801010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Senores Pharmaceuticals Ltd. listed?
Senores Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is SENORES and the BSE code is -.
Where can I find the shareholding pattern of Senores Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Senores Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Senores Pharmaceuticals Ltd. on Sharpely?
Share price data for Senores Pharmaceuticals Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.